Highbridge Capital Management LLC Gilead Sciences, Inc. Transaction History

Highbridge Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $1.91 Million - $2.49 Million	-31,541 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $12.4 Million - $13.7 Million	-173,889 Reduced 84.65%	31,541 $2.44 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $14.1 Million - $16.5 Million	197,564 Added 2511.62%	205,430 $14.7 Million
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $15.7 Million - $18.7 Million	-218,366 Reduced 96.52%	7,866 $637,000
Q2 2017 Aug 14, 2017	BUY	N/A	226,232	226,232 $16 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.